Virtus LifeSci Backtesting

Virtus LifeSci Biotech Clinical Trls ETF -- USA Etf  

USD 30.86  0.05  0.16%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of Virtus LifeSci Biotech Clinical Trls ETF and determine expected loss or profit from investing in Virtus LifeSci over given investment horizon. Check also Virtus LifeSci Hype Analysis, Virtus LifeSci Correlation, Portfolio Optimization, Virtus LifeSci Volatility as well as analyze Virtus LifeSci Alpha and Beta and Virtus LifeSci Performance.
 Time Horizon     30 Days    Login   to change
SymbolX
Backtest

Virtus LifeSci 'What if' Analysis

February 24, 2018
0.00
No Change 0.00  0.0%
In 2 months and 2 days
April 25, 2018
0.00
If you would invest  0.00  in Virtus LifeSci on February 24, 2018 and sell it all today you would earn a total of 0.00 from holding Virtus LifeSci Biotech Clinical Trls ETF or generate 0.0% return on investment in Virtus LifeSci over 60 days. Virtus LifeSci is related to or competes with Financial Select, Technology Select, Energy Select, Vanguard Information, Health Care, Consumer Discret, and INDUSTRIAL SPDR. The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of...

Virtus LifeSci Upside/Downside Indicators

Information Ratio0.053688
Maximum Drawdown9.7
Value At Risk3.37
Potential Upside3.18
  

Virtus LifeSci Market Premium Indicators

Risk Adjusted Performance0.10
Jensen Alpha0.15
Total Risk Alpha0.11
Treynor Ratio0.47

Virtus LifeSci Biotech Backtested Returns

Macroaxis considers Virtus LifeSci to be not too volatile. Virtus LifeSci Biotech owns Efficiency Ratio (i.e. Sharpe Ratio) of -0.0941 which indicates Virtus LifeSci Biotech had -0.0941% of return per unit of risk over the last 2 months. Macroaxis philosophy towards measuring risk of any etf is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. Virtus LifeSci Biotech Clinical Trls ETF exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to validate Virtus LifeSci Coefficient Of Variation of 1,580 and Risk Adjusted Performance of 0.10 to confirm risk estimate we provide. The entity has beta of 0.3317 which indicates as returns on market increase, Virtus LifeSci returns are expected to increase less than the market. However during bear market, the loss on holding Virtus LifeSci will be expected to be smaller as well.. Even though it is essential to pay attention to Virtus LifeSci Biotech current price movements, it is always good to be careful when utilizing equity historical returns. Macroaxis philosophy towards measuring future performance of any etf is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Virtus LifeSci Biotech Clinical Trls ETF exposes twenty-one different technical indicators which can help you to evaluate its performance.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation(0.30) 

Weak reverse predictability

Virtus LifeSci Biotech Clinical Trls ETF has weak reverse predictability. Overlapping area represents the amount of predictability between Virtus LifeSci time series from February 24, 2018 to March 26, 2018 and March 26, 2018 to April 25, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Virtus LifeSci Biotech price movement. The serial correlation of -0.3 indicates that nearly 30.0% of current Virtus LifeSci price fluctuation can be explain by its past prices. Given that Virtus LifeSci Biotech Clinical Trls ETF has negative autocorrelation for selected time horizon, investors may consider taking a contrarian position regarding future price movement of Virtus LifeSci for similar time interval.
Correlation Coefficient -0.3
Spearman Rank Test -0.13
Price Variance 1.05
Lagged Price Variance 0.57

Virtus LifeSci Biotech lagged returns against current returns

 Current and Lagged Values 
      Timeline 

Virtus LifeSci regressed lagged prices vs. current prices

 Current vs Lagged Prices 
      Timeline 

Virtus LifeSci Lagged Returns

 Regressed Prices 
      Timeline 

Current Sentiment - BBC

Virtus LifeSci Biotech Investor Sentiment
Greater number of Macroaxis users are currently bullish on Virtus LifeSci Biotech Clinical Trls ETF. What is your outlook on investing in Virtus LifeSci Biotech Clinical Trls ETF? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

BATS Exchange Efficient Frontier

Diversify in USA Market
The main assumption in equity investing is that a higher degree of volatility (or risk) means a higher potential (or expected) return on investment. Conversely, investors who take on a low degree of risk have a low expection for return.
Diversify Portfolios
You can create optimal portfolios in USA market or optimize your existing portfolio in one of two ways: 1) For any level of risk, select the one which has the highest expected return. 2) For any expected return, select the one which has the lowest volatility.
Diversify Portfolios
Check also Virtus LifeSci Hype Analysis, Virtus LifeSci Correlation, Portfolio Optimization, Virtus LifeSci Volatility as well as analyze Virtus LifeSci Alpha and Beta and Virtus LifeSci Performance. Please also try Balance Of Power module to check stock momentum by analyzing balance of power indicator and other technical ratios.